Infant mortality related to congenital heart disease in the United States, 1999–2025: trends, disparities, and projections to 2040
Authors:
- Alaa EldeebAEAlaa Eldeeb
- Raveen MujeebRMRaveen Mujeeb
- Alyaa Ahmed IbrahimAIAlyaa Ahmed Ibrahim
- Mahmoud TablawyMTMahmoud Tablawy
- Krish PatelKPKrish Patel
- Karim Othman AbdelnaimKAKarim Othman Abdelnaim
- Fizzah Ikram Ul HaqFHFizzah Ikram Ul Haq
- Mohammed ElshiekhMEMohammed Elshiekh
- Mohamed Fawzi HemidaMHMohamed Fawzi Hemida
Open Access
- 12 November 2026
- journal article
- research article
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1) , 886
Abstract
Introduction: Congenital heart disease remains a leading congenital cause of infant mortality in the United States despite major advances in diagnosis and neonatal care. This study evaluated national mortality trends from 1999 to 2025, examined sex and racial disparities, and projected future burden through 2040 using time-series forecasting. Methods: A retrospective CDC WONDER analysis examined U.S. infant (< 1 year) CHD mortality from 1999 to 2025 using ICD-10 codes Q20–Q26. Deaths listing CHD as underlying or contributing cause were included. Crude mortality rates (CMRs) per 100,000 with 95% CIs were calculated. Trends were evaluated using Joinpoint regression analysis to estimate annual percent change (APC) and average annual percent change (AAPC). Forecasts to 2040 used ARIMA and ETS models, stratified by sex and race/ethnicity. Results: From 1999 to 2025, 55,719 infant deaths related to CHD were recorded in the United States, 92.16% in medical facilities. The CMRs declined from 69.66 in 1999 to 46.44 in 2025 (AAPC − 1.32%) and is projected at 37.51 by 2040. Male mortality remained higher than female (54.86 vs. 52.04). NH Black infants had the highest mean mortality (71.87), while NH Asian/Pacific Islander infants showed the steepest decline (AAPC − 2.30%). Recent increases appeared in NH White infants after 2018 (APC 1.56%) and Hispanic infants after 2020 (APC 3.48%) overall. Conclusion: Infant CHD related mortality declined substantially from 1999 to 2025 and is projected to continue decreasing through 2040; however, persistent excess mortality in male, NH Black, and Hispanic infants underscores enduring demographic disparities in outcomes.Keywords
This publication has 18 references indexed in Scilit:
- National Trends and Disparities in Congenital Heart Disease Mortality in the United States, 1999–2024Pediatric Cardiology, 2026
- Congenital heart disease: types, pathophysiology, diagnosis, and treatment optionsMedcomm, 2024
- Structural Racism, Social Determinants of Health, and Provider Bias: Impact on Brain Development in Critical Congenital Heart DiseaseCanadian Journal of Cardiology, 2022
- Geographical variation in infant mortality due to congenital heart disease in the USA: a population-based cohort studyThe Lancet Child & Adolescent Health, 2021
- Racial and socioeconomic disparities in congenital heart surgery: A research articleJournal of Cardiac Surgery, 2021
- Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort studyBMJ Open, 2019
- Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studiesInternational Journal of Epidemiology, 2019
- Birth Prevalence of Congenital Heart Disease WorldwideJACC, 2011
- The Natural and Unnatural History of Congenital Heart Disease2009
- Prevalence of Congenital Heart Defects in Metropolitan Atlanta, 1998-2005The Journal of Pediatrics, 2008